title: Helicobacter pylori infection in women with Hashimoto thyroiditis: A case-control study.
abstract: An association between Helicobacter pylori (H pylori) infection as environmental risk factors for Hashimoto thyroiditis (HT) has been reported. We investigated this hypothesis in women in which HT is more common. Serum immunoglobulin G antibodies against H pylori (enzyme-linked immunosorbent assay), CagA protein (Western blot assay), circulating antibodies to thyroid antigens, mainly thyroperoxidase (TPOAbs) and thyroglobulin (TgAbs), were tested in 101 females with HT and 111 non-HT control women without a history of autoimmune disease. Thyroid function, socioeconomic status at childhood, and family history of thyroid malfunction were also studied. Forty-seven HT women (46.5%) tested seropositive for H pylori versus 48 controls (43.2%; P = 0.63). The prevalence of anti-CagA antibodies was 21.3% in HT-infected patients and 31.2% in infected controls (P = 0.352). Women with HT were older than the controls at a significance level of 0.03, and higher prevalence of hypothyroidism (69% vs 13.5%, respectively) and family history of thyroid malfunction (59% vs 34%, respectively) (P < 0.001 in both). Body mass index, diaphragmatic hernia, peptic ulcer, heartburn, use of proton pump inhibitors, childhood socioeconomic background, and crowding index showed no significant difference between HT-positive or negative individuals. Multivariate analysis demonstrated that H pylori seropositivity was not associated with HT (odds ratio 1.15, 95% confidence interval 0.57-1.83, P = 0.95) and that family thyroid malfunction was independently associated with an increased risk of HT (odds ratio 3.39, 95% confidence interval 1.86-6.18, P < 0.001). No association was found between H pylori infection and HT in women. Family history of thyroid malfunction is a risk factor for HT.
authors.affiliation: Department of Internal Medicine D, Helicobacter Institute, Kaplan Medical Center, Rehovot and the Faculty of Medicine, Hebrew University, Jerusalem, Rehovot, Israel Institute of Endocrinology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
authors.forename: Haim
authors.initials: H
authors.lastname: Shmuely
authors.forename: Ilan
authors.initials: I
authors.lastname: Shimon
authors.forename: Limor Azulay
authors.initials: LA
authors.lastname: Gitter
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D020022:Genetic Predisposition to Disease; D050031:Hashimoto Disease / Q000235:genetics / Q000276:immunology*; D016481:Helicobacter Infections / Q000235:genetics / Q000276:immunology*; D016480:Helicobacter pylori; D006801:Humans; D007557:Israel; D008875:Middle Aged; D012307:Risk Factors; D013960:Thyroid Function Tests
chemical_list: D015415:Biomarkers